Cheng-Fu Xu (Chengfu Xu)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 49

Top Topics

Endoscopic Submucosal Dissection

Helicobacter Pylori

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Digestive diseases and sciences

Journal of diabetes investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Miao Xu, Yi Lin, Naibin Yang, Jialin Li, Li Li, Huiqing Ding, Cheng-Fu Xu
Relationship between skeletal muscle mass loss and metabolic dysfunction-associated fatty liver disease among Chinese patients with metabolic dysregulation. Revista da Associacao Medica Brasileira (1992) 70 (3) (2024)
Miao Xu, Yi Lin, Naibin Yang, Jialin Li, Li Li, Huiqing Ding, Cheng-Fu Xu
Relationship between skeletal muscle mass loss and metabolic dysfunction-associated fatty liver disease among Chinese patients with metabolic dysregulation. Revista da Associacao Medica Brasileira (1992) 70 (3) (2024)
Miao Xu, Yi Lin, Naibin Yang, Jialin Li, Li Li, Huiqing Ding, Cheng-Fu Xu
Relationship between skeletal muscle mass loss and metabolic dysfunction-associated fatty liver disease among Chinese patients with metabolic dysregulation. Revista da Associacao Medica Brasileira (1992) 70 (3) (2024)
Hangkai Huang, Zhening Liu, Yanjun Guo, Yan Zeng, Shuxia Shen, Cheng-Fu Xu
Long-term Use of Proton Pump Inhibitors is Associated With An Increased Risk of Nonalcoholic Fatty Liver Disease. Journal of clinical gastroenterology 58 (3) (2024)
Zhening Liu, Hangkai Huang, Jiarong Xie, Yingying Xu, Cheng-Fu Xu
Circulating fatty acids and risk of hepatocellular carcinoma and chronic liver disease mortality in the UK Biobank. Nature communications 15 (1) (2024)
Zhening Liu, Hangkai Huang, Jiarong Xie, Yingying Xu, Cheng-Fu Xu
Circulating fatty acids and risk of hepatocellular carcinoma and chronic liver disease mortality in the UK Biobank. Nature communications 15 (1) (2024)
Zhening Liu, Hangkai Huang, Jiarong Xie, Yingying Xu, Cheng-Fu Xu
Circulating fatty acids and risk of hepatocellular carcinoma and chronic liver disease mortality in the UK Biobank. Nature communications 15 (1) (2024)
Hangkai Huang, Zhening Liu, Yanjun Guo, Yan Zeng, Shuxia Shen, Cheng-Fu Xu
Long-term Use of Proton Pump Inhibitors is Associated With An Increased Risk of Nonalcoholic Fatty Liver Disease. Journal of clinical gastroenterology 58 (3) (2024)
Hangkai Huang, Zhening Liu, Yanjun Guo, Yan Zeng, Shuxia Shen, Cheng-Fu Xu
Long-term Use of Proton Pump Inhibitors is Associated With An Increased Risk of Nonalcoholic Fatty Liver Disease. Journal of clinical gastroenterology 58 (3) (2024)
Zhening Liu, Hangkai Huang, Jiarong Xie, Yingying Xu, Cheng-Fu Xu
Circulating fatty acids and risk of hepatocellular carcinoma and chronic liver disease mortality in the UK Biobank. Nature communications 15 (1) (2024)
Zhening Liu, Hangkai Huang, Jiarong Xie, Cheng-Fu Xu
Dietary Patterns and Long-Term Outcomes in Patients with NAFLD: A Prospective Analysis of 128,695 UK Biobank Participants. Nutrients 15 (2) (2023)
Hangkai Huang, Jiarong Xie, Linxiao Hou, Min Miao, Lei Xu, Cheng-Fu Xu
Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations. Journal of diabetes investigation 15 (4) (2023)
Zhening Liu, Hangkai Huang, Jiarong Xie, Cheng-Fu Xu
Associations of serum uric acid levels with liver disease-related morbidity and mortality: A prospective cohort study of the UK Biobank. Liver international : official journal of the International Association for the Study of the Liver (2023)
Zhening Liu, Hangkai Huang, Jiarong Xie, Cheng-Fu Xu
Dietary Patterns and Long-Term Outcomes in Patients with NAFLD: A Prospective Analysis of 128,695 UK Biobank Participants. Nutrients 15 (2) (2023)
Jiarong Xie, Lei Xu, Hangkai Huang, Yishu Chen, Jinghua Wang, Youming Li, Chaohui Yu, Cheng-Fu Xu
A simpler definition of MAFLD precisely predicts incident metabolic diseases: a 7-year cohort study. Hepatology international (2023)
Zhening Liu, Hangkai Huang, Jiarong Xie, Cheng-Fu Xu
Dietary Patterns and Long-Term Outcomes in Patients with NAFLD: A Prospective Analysis of 128,695 UK Biobank Participants. Nutrients 15 (2) (2023)
Hangkai Huang, Jiarong Xie, Yan Zeng, Zhening Liu, Min Miao, Lei Xu, Cheng-Fu Xu
Remnant cholesterol independently predicts the development of nonalcoholic fatty liver disease. The Journal of clinical endocrinology and metabolism (2023)
Zhening Liu, Hangkai Huang, Jiarong Xie, Cheng-Fu Xu
Dietary Patterns and Long-Term Outcomes in Patients with NAFLD: A Prospective Analysis of 128,695 UK Biobank Participants. Nutrients 15 (2) (2023)
Pan Zhuang, Xiaohui Liu, Yin Li, Yuqi Wu, Haoyu Li, Xuzhi Wan, Lange Zhang, Cheng-Fu Xu, Jingjing Jiao, Yu Zhang
Circulating fatty acids, genetic risk, and incident coronary artery disease: A prospective, longitudinal cohort study. Science advances 9 (38) (2023)
Hangkai Huang, Jiarong Xie, Linxiao Hou, Min Miao, Lei Xu, Cheng-Fu Xu
Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations. Journal of diabetes investigation (2023)
Tian-Lian Yan, Jing-Hua Wang, Xin-Jue He, Ya-Bi Zhu, Lin-Jie Lu, Yan-Jiao Wang, Zi-Wei Wang, Jian-Guo Gao, Cheng-Fu Xu, Han Ma, Shuang-Mei Luan, Lan Li, Yi Chen
Ten-day vonoprazan-amoxicillin dual therapy versus standard fourteen-day Bismuth-based quadruple therapy for first-line Helicobacter pylori eradication: a multicenter randomized clinical trial. The American journal of gastroenterology (2023)
Hangkai Huang, Jiarong Xie, Linxiao Hou, Min Miao, Lei Xu, Cheng-Fu Xu
Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations. Journal of diabetes investigation 15 (4) (2023)
Hangkai Huang, Jiarong Xie, Linxiao Hou, Min Miao, Lei Xu, Cheng-Fu Xu
Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations. Journal of diabetes investigation 15 (4) (2023)
Zhening Liu, Hangkai Huang, Jiarong Xie, Cheng-Fu Xu
Dietary Patterns and Long-Term Outcomes in Patients with NAFLD: A Prospective Analysis of 128,695 UK Biobank Participants. Nutrients 15 (2) (2023)
Jiahui Hu, Dongdong Huang, Cheng-Fu Xu, Yi Chen, Han Ma, Zhe Shen
Epstein-Barr Virus-Positive Inflammatory Follicular Dendritic Cell Sarcoma Presenting as a Colonic Polyp: Report of a Case with a Literature Review. Medicina (Kaunas, Lithuania) 59 (7) (2023)
Meng Li, Xin Song, Cheng-Fu Xu, Chaohui Yu
Response to the clinical significance and prognostic value of 3-mercaptopyruvate sulfurtransferase in hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 42 (7) (2022)
Shuxia Shen, Hangkai Huang, Jinghua Wang, Zexi Tang, Chao Shen, Cheng-Fu Xu
Positive Association Between the Chinese Visceral Adiposity Index and Nonalcoholic Fatty Liver Disease in Lean Adults. Digestive diseases and sciences (2022)
Shuxia Shen, Hangkai Huang, Jinghua Wang, Zexi Tang, Chao Shen, Cheng-Fu Xu
Positive Association Between the Chinese Visceral Adiposity Index and Nonalcoholic Fatty Liver Disease in Lean Adults. Digestive diseases and sciences 68 (2) (2022)
Shuxia Shen, Hangkai Huang, Jinghua Wang, Zexi Tang, Chao Shen, Cheng-Fu Xu
Positive Association Between the Chinese Visceral Adiposity Index and Nonalcoholic Fatty Liver Disease in Lean Adults. Digestive diseases and sciences 68 (2) (2022)
Mengli Yu, Xin-Jue He, Xin Song, Jianguo Gao, Jiaqi Pan, Tianyu Zhou, Qinqiu Wang, Wei Zhu, Huijian Ma, Hang Zeng, Cheng-Fu Xu, Chaohui Yu
Biglycan promotes hepatic fibrosis through activating heat shock protein 47. Liver international : official journal of the International Association for the Study of the Liver (2022)
Hangkai Huang, Yanjun Guo, Zhening Liu, Yan Zeng, Yishu Chen, Cheng-Fu Xu
Remnant Cholesterol Predicts Long-term Mortality of Patients With Metabolic Dysfunction-associated Fatty Liver Disease. The Journal of clinical endocrinology and metabolism 107 (8) (2022)
Hangkai Huang, Linjie Lu, Yishu Chen, Yan Zeng, Cheng-Fu Xu
The efficacy of vitamin D supplementation for irritable bowel syndrome: a systematic review with meta-analysis. Nutrition journal 21 (1) (2022)
Shuxia Shen, Hangkai Huang, Jinghua Wang, Zexi Tang, Chao Shen, Cheng-Fu Xu
Positive Association Between the Chinese Visceral Adiposity Index and Nonalcoholic Fatty Liver Disease in Lean Adults. Digestive diseases and sciences 68 (2) (2022)
Jiarong Xie, Lei Xu, Cheng-Fu Xu
Editorial: time to eat? Skipping breakfast in metabolic-associated fatty liver disease-Authors' reply. Alimentary pharmacology & therapeutics 55 (4) (2022)
Peihao Liu, Yu Wei Zhang, Chenxi Tang, Li Cen, Yishu Chen, Sha Li, Xueyang Chen, Mengli Yu, Jie Zhang, Xiaofen Zhang, Hang Zeng, Cheng-Fu Xu, Chaohui Yu
The DEAD-box helicase DDX3x ameliorates non-alcoholic fatty liver disease via mTORC1 signalling pathway. Liver international : official journal of the International Association for the Study of the Liver 42 (8) (2022)
Shuxia Shen, Hangkai Huang, Jinghua Wang, Zexi Tang, Chao Shen, Cheng-Fu Xu
Positive Association Between the Chinese Visceral Adiposity Index and Nonalcoholic Fatty Liver Disease in Lean Adults. Digestive diseases and sciences 68 (2) (2022)
Meng Li, Xin Song, Qi Jin, Yishu Chen, Jie Zhang, Jian-Guo Gao, Li Cen, Yiming Lin, Cheng-Fu Xu, Xin-Jue He, You-Ming Li, Chaohui Yu
3-Mercaptopyruvate sulfurtransferase represses tumour progression and predicts prognosis in hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 42 (5) (2022)
Jiarong Xie, Hangkai Huang, Zhening Liu, Youming Li, Chaohui Yu, Lei Xu, Cheng-Fu Xu
The associations between modifiable risk factors and nonalcoholic fatty liver disease: A comprehensive Mendelian randomization study. Hepatology (Baltimore, Md.) (2022)
Yanjun Guo, Hangkai Huang, Yishu Chen, Chao Shen, Cheng-Fu Xu
Association between circulating cystatin C and hyperuricemia: a cross-sectional study. Clinical rheumatology 41 (7) (2022)
Shenghui Chen, Zhening Liu, Li Cen, Jinghua Wang, Juanwen Zhang, Xiaofeng Zhang, Cheng-Fu Xu
Association Between Serum Afamin Levels with Nonalcoholic Associated Fatty Liver Disease. Canadian journal of gastroenterology & hepatology 2022 (2022)
Jiarong Xie, Lei Xu, Cheng-Fu Xu
Letter: skipping breakfast is associated with an increased long-term cardiovascular mortality in metabolic dysfunction-associated fatty liver disease (MAFLD) but not in MAFLD-free individuals. Authors' reply. Alimentary pharmacology & therapeutics 55 (8) (2022)
Qinqiu Wang, Xiaoying Shi, Jinghua Wang, Juanwen Zhang, Cheng-Fu Xu
Low serum vitamin D concentrations are associated with obese but not lean NAFLD: a cross-sectional study. Nutrition journal 20 (1) (2021)
Jiarong Xie, Hangkai Huang, Yishu Chen, Lei Xu, Cheng-Fu Xu
Skipping breakfast is associated with an increased long-term cardiovascular mortality in metabolic dysfunction-associated fatty liver disease (MAFLD) but not MAFLD-free individuals. Alimentary pharmacology & therapeutics (2021)
Hangkai Huang, Jinghua Wang, Lei Xu, Min Miao, Cheng-Fu Xu
Association between High-Density Lipoprotein Cholesterol to Apolipoprotein A-I Ratio and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study. International journal of endocrinology 2021 (2021)
Jinghua Wang, Yishu Chen, Ran Pan, Chao Wu, Shenghui Chen, Lan Li, You-Ming Li, Chaohui Yu, Zhuo-Xian Meng, Cheng-Fu Xu
Leukocyte cell-derived chemotaxin 2 promotes the development of nonalcoholic fatty liver disease through STAT-1 pathway in mice. Liver international : official journal of the International Association for the Study of the Liver 41 (4) (2021)
Hangkai Huang, Qinqiu Wang, Xiaoying Shi, Yishu Chen, Chao Shen, Juanwen Zhang, Cheng-Fu Xu
Association between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study. Mediators of inflammation 2021 (2021)
Chao Shen, Xiaoying Shi, Maram Al-Ashoor, Cheng-Fu Xu
Association between Hemoglobin Levels and Colorectal Polyps in Asymptomatic Chinese Adults. Gastroenterology research and practice 2020 (2020)
Shenghui Chen, Dan Chen, Hua Yang, Xinyu Wang, Jinghua Wang, Cheng-Fu Xu
Uric acid induced hepatocytes lipid accumulation through regulation of miR-149-5p/FGF21 axis. BMC gastroenterology 20 (1) (2020)
Ya-Nan Zhang, Qin-Qiu Wang, Yi-Shu Chen, Chao Shen, Cheng-Fu Xu
Association between Serum Uric Acid to HDL-Cholesterol Ratio and Nonalcoholic Fatty Liver Disease in Lean Chinese Adults. International journal of endocrinology 2020 (2020)